Published in Diabetologia on January 01, 1990
Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell (1987) 5.80
SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem (2001) 3.09
SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem (2000) 2.61
125I-insulin binding to cultured human lymphocytes. Initial localization and fate of hormone determined by quantitative electron microscopic autoradiography. J Clin Invest (1978) 2.47
A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis. Mol Cell Biol (1987) 2.36
Insulin-induced receptor loss in cultured human lymphocytes is due to accelerated receptor degradation. Proc Natl Acad Sci U S A (1981) 2.18
The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J (2000) 2.08
Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites. EMBO J (1988) 1.92
Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking. J Biol Chem (1981) 1.90
Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J Biol Chem (1996) 1.86
Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem (1994) 1.84
Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology (1997) 1.73
Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes. Proc Natl Acad Sci U S A (1981) 1.72
Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase. Mol Cell Biol (1999) 1.68
Insulin receptors, receptor antibodies, and the mechanism of insulin action. Recent Prog Horm Res (1981) 1.68
Direct demonstration of glycosylation of insulin receptor subunits by biosynthetic and external labeling: evidence for heterogeneity. Proc Natl Acad Sci U S A (1981) 1.64
Internalized insulin receptors are recycled to the cell surface in rat hepatocytes. Proc Natl Acad Sci U S A (1982) 1.63
Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest (1993) 1.62
Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin. Nature (1978) 1.55
Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice. Nature (1985) 1.50
Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem (1994) 1.49
Receptor-mediated phosphorylation of the hepatic insulin receptor: evidence that the Mr 95,000 receptor subunit is its own kinase. Proc Natl Acad Sci U S A (1983) 1.49
The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro. J Biol Chem (1993) 1.48
Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. J Biol Chem (1996) 1.46
Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem (2001) 1.45
Structural similarity between Fc receptors and T cell receptors. Expression of the gamma-subunit of Fc epsilon RI in human T cells, natural killer cells and thymocytes. J Immunol (1991) 1.44
Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist. Biochem J (1993) 1.41
Modulation of insulin action. Diabetologia (2004) 1.41
MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632. Diabetologia (2003) 1.40
Identification of the rat adapter Grb14 as an inhibitor of insulin actions. J Biol Chem (1998) 1.38
Insulin signalling downstream of protein kinase B is potentiated by 5'AMP-activated protein kinase in rat hearts in vivo. Diabetologia (2005) 1.37
Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation. J Biol Chem (1990) 1.36
Phosphorylation of the hepatic insulin receptor: stimulating effect of insulin on intact cells and in a cell-free system. FEBS Lett (1982) 1.35
Glucose, other secretagogues, and nerve growth factor stimulate mitogen-activated protein kinase in the insulin-secreting beta-cell line, INS-1. J Biol Chem (1995) 1.33
Effect of phosphoinositide-dependent kinase 1 on protein kinase B translocation and its subsequent activation. Mol Cell Biol (2000) 1.32
Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786. J Biol Chem (1996) 1.31
cAMP stimulates protein kinase B in a Wortmannin-insensitive manner. FEBS Lett (1997) 1.31
Protein kinase activity of the insulin receptor. Biochem J (1986) 1.31
Receptor-mediated endocytosis of insulin: role of microvilli, coated pits, and coated vesicles. Proc Natl Acad Sci U S A (1982) 1.30
Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem (2000) 1.30
SOCS proteins causing trouble in insulin action. Acta Physiol (Oxf) (2008) 1.30
Surface redistribution of 125I-insulin in cultured human lymphocytes. J Cell Biol (1981) 1.27
Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem J (1994) 1.26
Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity. Diabetologia (2010) 1.21
Insulin and okadaic acid induce Rab4 redistribution in adipocytes. J Biol Chem (1993) 1.20
Molecular association between major histocompatibility complex class I antigens and insulin receptors in mouse liver membranes. Proc Natl Acad Sci U S A (1985) 1.19
Role of microtubules in the phasic pattern of insulin release. Ann N Y Acad Sci (1975) 1.19
Involvement of the pleckstrin homology domain in the insulin-stimulated activation of protein kinase B. J Biol Chem (1998) 1.18
p125Fak focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-I tyrosine kinase receptors. J Biol Chem (1998) 1.18
Sustained recruitment of phospholipase C-gamma to Gab1 is required for HGF-induced branching tubulogenesis. Oncogene (2000) 1.15
Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol Endocrinol (2003) 1.15
Identification of a cellular 110 000-Da protein substrate for the insulin-receptor kinase. Biochem J (1985) 1.15
Different effects of insulin and platelet-derived growth factor on phosphatidylinositol 3-kinase at the subcellular level in 3T3-L1 adipocytes. A possible explanation for their specific effects on glucose transport. Eur J Biochem (1996) 1.13
Polypeptide hormone degradation and receptor regulation are coupled to ligand internalization. A direct biochemical and morphologic demonstration. J Biol Chem (1981) 1.12
Nerve growth factor-induced phosphorylation cascade in PC12 pheochromocytoma cells. Association of S6 kinase II with the microtubule-associated protein kinase, ERK1. J Biol Chem (1992) 1.11
Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase alpha (PI3Kalpha ). Functions of lipid kinase-deficient PI3Kalpha in signaling. J Biol Chem (2001) 1.11
AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC. Am J Physiol Endocrinol Metab (2009) 1.11
Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor. Eur J Biochem (1994) 1.10
The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. J Biol Chem (2001) 1.09
Cell surface receptors for insulin and human growth hormone. Effect of microtubule and microfilament modifiers. J Biol Chem (1976) 1.09
Dynamics of insulin release and microtubular-microfilamentous system. VII. Do microfilaments provide the motive force for the translocation and extrusion of beta granules? Diabetes (1975) 1.07
Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase. J Biol Chem (2001) 1.06
Subcellular distribution of low molecular weight guanosine triphosphate-binding proteins in adipocytes: colocalization with the glucose transporter Glut 4. Endocrinology (1991) 1.04
Two different protein kinase activities are associated with the insulin receptor. Biochem J (1983) 1.04
Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimerae. EMBO J (1989) 1.04
Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system. J Biol Chem (1995) 1.03
Insulin and antibodies against insulin receptor cap on the membrane of cultured human lymphocytes. Nature (1980) 1.03
Binding, internalization, and lysosomal association of 125I-human growth hormone in cultured human lymphocytes: a quantitative morphological and biochemical study. J Cell Biol (1980) 1.02
Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor. Endocrinology (1998) 1.01
Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein. Biochem J (1989) 1.01
Desensitization of the insulin receptor at an early postreceptor step by prolonged exposure to antireceptor antibody. Proc Natl Acad Sci U S A (1979) 1.01
Galanin can inhibit insulin release by a mechanism other than membrane hyperpolarization or inhibition of adenylate cyclase. J Biol Chem (1989) 1.01
Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. Diabetologia (2011) 0.99
Antibody-induced desensitization of the insulin receptor. Studies of the mechanism of desensitization in 3T3-L1 fatty fibroblasts. J Clin Invest (1980) 0.99
Two types of receptor for insulin-like growth factors in mammalian brain. EMBO J (1985) 0.99
Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle: comparison with fat cells. Endocrinology (1995) 0.99
Glucocorticoid-induced insulin resistance in vitro: evidence for both receptor and postreceptor defects. Endocrinology (1981) 0.98
Redistribution of 125I-insulin on the surface of rat hepatocytes as a function of dissociation time. Diabetes (1985) 0.98
Insulin induces a change in Rab5 subcellular localization in adipocytes independently of phosphatidylinositol 3-kinase activation. Endocrinology (1996) 0.97
Fatty acid-induced insulin resistance: role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling. Biochem Soc Trans (2003) 0.97
Effects of okadaic acid, an inhibitor of protein phosphatases-1 and -2A, on glucose transport and metabolism in skeletal muscle. J Biol Chem (1991) 0.97
Immunoprecipitation of insulin receptors by antibodies against Class 1 antigens of the murine H-2 major histocompatibility complex. FEBS Lett (1983) 0.97
Insulin-receptor antibodies mimic a late insulin effect. Nature (1979) 0.97
Thermodynamics of the interaction of insulin with its receptor. J Biol Chem (1979) 0.97
Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules. Mol Endocrinol (1998) 0.96
Tyrosine and threonine phosphorylation of an immunoaffinity-purified 44-kDa MAP kinase. Biochemistry (1991) 0.96
Assays of glucose entry, glucose transporter amount, and translocation. Methods Mol Biol (2001) 0.96
Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis. Leukemia (2004) 0.96
Signaling function of reconstituted CD16: zeta: gamma receptor complex isoforms. Int Immunol (1992) 0.96
Insulin receptor substrate-1 as a signaling molecule for focal adhesion kinase pp125(FAK) and pp60(src). J Biol Chem (1998) 0.96
Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 3-kinase and Akt activities exert opposing effects on the ERK pathway: importance for the rescue of neuroectodermic cells. J Biol Chem (2001) 0.94
Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP. FEBS Lett (1995) 0.94